Organogenesis Holdings (ORGO) Change in Inventory (2018 - 2026)
Organogenesis Holdings' (ORGO) quarterly Change in Inventory came in at $8.7 million in Q1 2026, little changed year-on-year from $8.7 million in Q1 2025, and up 194.83% quarter-over-quarter from $3.0 million in Q4 2025.
Organogenesis Holdings (ORGO) Change in Inventory (2018 - 2026) Analysis & Trends
Organogenesis Holdings' Change in Inventory history runs 9 years deep, the most recent figure standing at $8.7 million for Q1 2026.
- On a quarterly basis, Change in Inventory changed 0.02% year-over-year to $8.7 million in Q1 2026; TTM through Mar 2026 was $17.9 million, a 74.49% increase from a year earlier, with the FY2025 full-year figure at $17.9 million, up 188.77% from the prior year.
- Change in Inventory rose to $8.7 million in Q1 2026 per ORGO's latest filing, from $3.0 million in the prior quarter.
- Across five years, Change in Inventory topped out at $8.7 million in Q1 2025 and bottomed at -$2.7 million in Q2 2024.
- The 5-year median for Change in Inventory is $3.0 million (2025), against an average of $3.0 million.
- Across the five-year window, Change in Inventory jumped 2803.75% in 2023 and tumbled 241.39% in 2024, its largest moves.
- Year by year, Change in Inventory stood at $2.1 million in 2022, then tumbled by 66.82% to $706000.0 in 2023, then sank by 35.55% to $455000.0 in 2024, then surged by 550.77% to $3.0 million in 2025, then soared by 194.83% to $8.7 million in 2026.
- Per Business Quant, the three latest ORGO Change in Inventory figures stand at $8.7 million (Q1 2026), $3.0 million (Q4 2025), and -$938000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -93.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 114.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 119.24 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 40.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 123.00 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -4.30 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Organogenesis Holdings | 310.55 Mn | 218.45 Mn | 11.46 Mn | 8.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.73 Mn |
| Mar 31, 2026 | 8.73 Mn |
| Dec 31, 2025 | 2.96 Mn |
| Dec 31, 2025 | 2.96 Mn |
| Sep 30, 2025 | -938,000.00 |
| Sep 30, 2025 | -938,000.00 |
| Jun 30, 2025 | 7.16 Mn |
| Jun 30, 2025 | 7.16 Mn |
| Mar 31, 2025 | 8.73 Mn |
| Mar 31, 2025 | 8.73 Mn |
| Dec 31, 2024 | 455,000.00 |
| Dec 31, 2024 | 455,000.00 |
| Sep 30, 2024 | 3.74 Mn |
| Sep 30, 2024 | 3.74 Mn |
| Jun 30, 2024 | -2.66 Mn |
| Jun 30, 2024 | -2.66 Mn |
| Mar 31, 2024 | 4.67 Mn |
| Mar 31, 2024 | 4.67 Mn |
| Dec 31, 2023 | 706,000.00 |
| Dec 31, 2023 | 706,000.00 |